Transgenic models for the study of prostate cancer

Cancer

Volumn 71, Issue 3 S, 1993, Pages 1165-1171

  Thompson, Timothy C ^a   Truong, Luan D ^b   Timme, Terry L ^a   Kadmon, Dov ^a   McCune, Bryan K ^a   Flanders, Kathleen C ^a   Scardino, Peter T ^a   Park, Sang Hee ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

oncogenes; organ reconstitution; prostate cancer; transforming growth factor beta; transgenic mice

Indexed keywords

ANIMAL MODEL; CANCER GROWTH; CARCINOGENESIS; CONFERENCE PAPER; GENE ACTIVITY; GENE EXPRESSION; GENETIC MARKER; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; ONCOGENE MYC; ONCOGENE RAS; PRIORITY JOURNAL; PROSTATE CANCER; TRANSGENIC MOUSE;

ANIMAL; DISEASE MODELS, ANIMAL; GENES, MYC; GENES, RAS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PROSTATIC NEOPLASMS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; TRANSFORMING GROWTH FACTOR BETA;

EID: 0027416389     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19930201)71:3+<1165::AID-CNCR2820711440>3.0.CO;2-U     Document Type: Article

References (45)

1. Cancer statistics, 1991. CA Cancer
2. The prostate: an increasing medical problem
3. Epidemiologic evidence regarding predisposing factors to prostate cancer
4. Clinical evidence for and implications of the multistep development of prostate cancer
5. Natural history of low‐stage prostatic cancer and the impact of early detection
6. Early detection of prostate cancer
7. Growth factors and oncogenes in prostate cancer
8. Allelic loss of chromosomes 16q and 10q in human prostate cancer
9. Frequency and pattern of karyotypic abnormalities in human prostate cancer
10. Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma
11. Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene
12. Wild‐type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles
13. Prevention of primary prostate cancer in Lobund‐Wistar rats by N‐4‐hydroxyphenyl retinamide
14. Dissecting multistep tumorigenesis in transgenic mice
15. The int‐2 gene product acts as an epithelial growth factor in transgenic mice
16. Detection and characterization of the fibroblast growth factorrelated oncoprotein int‐2
17. Sequence, topography and protein coding potential of mouse int‐2: a putative oncogene activated by mouse mammary tumour virus
18. Prostatic growth factor: purification and structural relationship to basic fibroblast growth factor
19. Heparin‐binding growth factor isolated from human prostatic extracts
20. Expression of basic fibroblast growth factor mRNA in benign prostatic hyperplasia and prostatic carcinoma
21. Increased expression of genes for basic fibroblast growth factor and transforming growth factor type β‐2 in human benign prostatic hyperplasia
22. The mouse mammary tumor virus long terminal repeat directs expression in epithelial and lymphoid cells of different tissues in transgenic mice
23. Endogenous mouse mammary tumor virus is expressed in several organs in addition to the lactating mammary gland
24. Restriction of neuroblastoma to the prostate gland in transgenic mice
25. Overexpression of TGF‐α in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast
26. Role of transforming growth factor‐alpha in human prostate cancer cell growth
27. Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ
28. Epithelial‐mesenchymal interactions in prostatic development: II. Morphological observations of prostatic induction by urogenital sinus mesenchyme in epithelium of the adult rodent urinary bladder
29. Epithelial‐mesenchymal interactions in prostatic development: II. Biochemical observations of prostatic induction by urogenital sinus mesenchyme in epithelium of the adult rodent urinary bladder
30. Androgen‐induced biochemical responses in epithelium lacking androgen receptors: characterization of androgen receptors in the mesenchymal derivative of urogenital sinus
31. Androgen‐regulated expression of secretory protein synthesis in mouse ventral prostate
32. Elevated TGF‐β1 and β3 mRNA levels are associated with ras + myc‐induced carcinomas in reconstituted mouse prostate: evidence for a paracrine role during progression
33. Transforming growth factorbeta 1: histochemical localization with antibodies to different epitopes
34. Type‐β transforming growth factor is a growth stimulator and growth inhibitor
35. Type beta transforming growth factor: a bifunctional regulator of cellular growth
36. Rat prostate cancer cells contain functional receptors for transforming growth factor‐β
37. Transforming growth factor type β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro
38. Cell‐mediated coaction of transforming growth factors: incubation of type β with normal rat kidney cells produces a soluble activity that prolongs the ruffling response to type α
39. Transforming growth factor‐β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix
40. Transforming growth factor‐β: multiple effects on cell differentiation and extracellular matrices
41. Growth factors and their receptors in differentiation and early murine development
42. Mediation of wound‐related Rous sarcoma virus tumorigenesis by TGF‐β
43. Transforming growth factor β stimulates mammary adenocarcinoma cell invasion and metastatic potential